SCHEMBL18155070

SCHEMBL18155070

C#COc1ccccc1C(=O)NO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 1/20 0.51
GAA P10253 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MPO P05164 1/20 0.48
HIF1A Q16665 1/20 0.48
LMNA P02545 1/20 0.47
HDAC8 Q9BY41 3/20 0.44
MMP3 P08254 1/20 0.44
CTSD P07339 1/20 0.42
STAT3 P40763 1/20 0.40
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
IDO1 P14902 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8975637 0.79 SLC6A3 (0.56) GAAKDM4ELMNACA1ALOX15
SCHEMBL6671288 0.76 CTSD (0.70) GAASMN1; SMN2LMNACTSDSTAT3
Hydrochloric Acid SCHEMBL31097029 0.74 CTSD (0.68) GAASMN1; SMN2LMNACTSDSTAT3
SCHEMBL9129759 0.74 LIG1 (0.54) LIG1GAASMN1; SMN2KDM4EMPO
SCHEMBL8975646 0.74 ABCB1 (0.46) KDM4EHSD17B10NPC1RAB9AHCRTR1
SCHEMBL1331243 0.73 GAA (0.73) LIG1GAASMN1; SMN2KDM4EMPO
SCHEMBL5302217 0.73 KDM4E (0.65) LIG1GAASMN1; SMN2KDM4EMPO
SCHEMBL974852 0.73 CTNNB1 (0.62) LIG1GAASMN1; SMN2KDM4EHDAC8
SCHEMBL28010210 0.73 KDM4E (0.65) LIG1GAASMN1; SMN2KDM4EMPO
SCHEMBL10780944 0.73 LIG1 (0.53) LIG1GAASMN1; SMN2KDM4EMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10562920-B2 Ln(III) and Ga(III) metallacrown complexes THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2020-02-18 US disclosed
US-20180127438-A1 LN(III) AND GA(III) METALLACROWN COMPLEXES NATIONAL SCIENCE FOUNDATION 2018-05-10 US disclosed
EP-3283497-A1 LN(III) AND GA(III) METALLACROWN COMPLEXES The Regents of The University of Michigan (US) 2018-02-21 EP disclosed
WO-2016166380-A1 LN(III) AND GA(III) METALLACROWN COMPLEXES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127438-A1 LN(III) AND GA(III) METALLACROWN COMPLEXES NEU3, GALNT3, LGALS3 LIG1 70/4885GAA 102/4885SMN1; SMN2 2890/4885
US-10562920-B2 Ln(III) and Ga(III) metallacrown complexes NEU3, GALNT3, LGALS3 LIG1 70/4885GAA 102/4885SMN1; SMN2 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.